No doubt capital will be needed, that’s why the 8 cent options were issued.
Currently it’s a case of when is that capital required and in what fashion will that capital raise take place.
The wish list would be the infusion sale contributes enough to get through another 1/4 or 2.
Sales increase substantially with the addition of eu which in turn drives a higher share price, then SIO and SB convert their options to provide capital and increase their positions. This is a wish list that I’d think management, SB and SIO would like to be a reality as well.
Under the Radar, page-441
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |